K Number
K250797
Device Name
UV5000 Handle
Manufacturer
Date Cleared
2025-09-11

(181 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The UV5000 Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

Device Description

The Uro-G Cystoscope System is comprised of a cannula and handle that is intended to allow visualization of the urethra, bladder, cervical canal, and uterine cavity for the purpose of performing diagnostics. This 510(k) discloses the modifications made to the handle of the Uro-G HD Cystoscope System (K232837), UV5000 Handle. The Uro-G HD Flexible Cystoscope System is a handheld, battery-operated portable cystoscope consisting of a disposable steerable endoscopic cannula with a 2.2 mm channel for fluid infusion and instrument advancement, and a reusable handle with a video monitor.

AI/ML Overview

N/A

FDA 510(k) Clearance Letter - UV5000 Handle

Page 1

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

Doc ID # 04017.08.00

September 11, 2025

UroViu Corporation
Thomas Lawson, Ph.D.
Director, Regulatory Affairs
4546 El Camino Real, Suite 214
Los Altos, CA 94022

Re: K250797
Trade/Device Name: UV5000 Handle
Regulation Number: 21 CFR§ 876.1500
Regulation Name: Endoscope and Accessories
Regulatory Class: II
Product Code: FAJ
Dated: March 14, 2025
Received: July 30, 2025

Dear Thomas Lawson:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Page 2

K250797 - Thomas Lawson, Ph.D.
Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

Page 3

K250797 - Thomas Lawson, Ph.D.
Page 3

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Mark R. Kreitz -S

for Mark J. Antonino, M.S.
Assistant Director
DHT3B: Division of Reproductive,
Gynecology and Urology Devices
OHT3: Office of GastroRenal, ObGyn,
General Hospital and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

Page 4

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.

510(k) Number (if known): K250797

Device Name: UV5000

Indications for Use (Describe)

The UV5000 Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

Type of Use (Select one or both, as applicable)

☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/23) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF

Page 5

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

510(k) SUMMARY

General Information

FieldValue
SubmitterUroViu Corporation
Address4546 El Camino RealSuite 214Los Altos, CA 94022
Correspondence PersonThomas Lawson, PhDDirector, Regulatory Affairs
Contact InformationEmail: thom@uroviu.comPhone: 510-206-1794
Date PreparedSeptember 9, 2025

Proposed Device

FieldValue
Trade NameUV5000 Handle
Common NameEndoscope and accessories
Regulation Number and Classification Name21 CFR§876.1500Cystoscope and Accessories, Flexible/Rigid
Product CodeFAJ
Regulatory ClassII

Note: This is the first 510(k) submission for this device.

Predicate Device

FieldValue
Trade NameUro-G HD Flexible Cystoscope
Common NameEndoscope and accessories
Premarket NotificationK232837
Regulation Number and Classification Name21 CFR§876.1500Endoscope and Accessories
Product CodeFAJ
Regulatory ClassII

Note: This predicate device has not been subject to a design-related recall.

K250797 Page 1of 10

Page 6

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Device Description

The Uro-G Cystoscope System is comprised of a cannula and handle that is intended to allow visualization of the urethra, bladder, cervical canal, and uterine cavity for the purpose of performing diagnostics. This 510(k) discloses the modifications made to the handle of the Uro-G HD Cystoscope System (K232837), UV5000 Handle. The Uro-G HD Flexible Cystoscope System is a handheld, battery-operated portable cystoscope consisting of a disposable steerable endoscopic cannula with a 2.2 mm channel for fluid infusion and instrument advancement, and a reusable handle with a video monitor.

Indications for Use

The indication for use for the UV5000 Handle is:

The UV5000 Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

Comparison to the Predicate Device

The focus of this Traditional 510(k) is the handle component of the Uro-G HD Flexible Cystoscope, which was reviewed in K232837 as the 4500 Handle. The UV5000 Handle is substantially equivalent to the U4500 Handle based upon the following equivalences:

  1. The intended use of both devices is the same.
  2. Both devices provide the means for the physician to view the urethra and bladder via the video monitor that is integrated into the body of the handle.

K250797 Page 2 of 10

Page 7

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Table 1 shows the comparison of the UV5000 Handle (the subject of this submission) to the predicate device, the 4500 Handle of the Uro-G HD Flexible Cystoscope. The similarities between the two devices satisfy the criteria for a 510(k) notice.

Table 1. Comparison of the UV5000 Handle to the predicate device, the 4500 Handle of the Uro-G HD Flexible Cystoscope.

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
Device Overview
Device ClassIIIISame
FDA Product CodeFAJFAJSame
Product Classification21 CFR 876.150021 CFR 876.1500Same
Intended UseUsed to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnosticsUsed to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnosticsSame
Indication for UseThe UV5000 Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavityThe Uro-G HD Flexible Cystoscope is intended for endoscopic diagnosis and infusion of irrigating fluids within the bladder and urethraSame

K250797 Page 3 of 10

Page 8

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
for the purpose of performing diagnostics.
ContraindicationsAs described in each UroViu cannula instructions for useAs described in each UroViu cannula instructions for useSame
Technical Characteristics
Device IdentityUV5000Uro-G HD Flexible Cystoscope (4500 handle)N/A
Components• 1 piece handle• 1 piece charging cradle• 1 piece USB cable• 1 piece handle• 1 piece charging cradle• 1 piece USB cableSame
Length178 mm176 mmEquivalentThe 2 mm difference in length does not introduce any new risk
Diameter38 mm36 mmEquivalentThe 2 mm increase in diameter is to accommodate a different size battery but this does not introduce any new risk
Weight345 g264 gEquivalentThe extra weight is mainly due to the increased size of the monitor and the larger capacity

K250797 Page 4 of 10

Page 9

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
battery and does not introduce any new risk
Monitor5 inches diagonal125.4 mm horizontal91.4 mm vertical4.3 inches diagonal122.2 mm horizontal73.9 mm verticalEquivalentThe slight larger monitor makes it easier for the user to view the image and does not introduce any new risk
Input formatRGBRGBSame
Effective pixels1280 x 7201280 x 720Same
LCD resolution1024 x 768800 x 480EquivalentIncreased resolution does not introduce any new risk
LCD display resolution0.8 million pixels0.4 million pixelsEquivalentIncreased resolution does not introduce any new risk
Power supply21700 Lithium Ion rechargeable battery18650 Lithium Ion rechargeable batteryEquivalentThe higher power supply necessary for the increased power consumption but it does not introduce any new risk in that it is compliant with IEC 60601-1 & 60601-2-18
Voltage of fully4.2 V3.7 VEquivalent

K250797 Page 5 of 10

Page 10

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
charged batteryThe 0.5 V increase in power supply is necessary for the increased power consumption but it does not introduce any new risk in that it is compliant with IEC 60601-1 & 60601-2-18
Time to obtain full charge4 hours4 hoursSame
Operating time after fully charged2 hours2 hoursSame
Battery capacity5000 mA3100 mAEquivalentThe higher capacity is necessary for the increased power consumption but it does not introduce any new risk in that it is compliant with IEC 60601-1 & IEC 60601-2-18
BiocompatibilityN/ADoes not contact the patient & the user wears gloves while using the deviceN/ADoes not contact the patient & the user wears gloves while using the deviceSame
Operational Characteristics
Electrical SafetyIEC 60601-1 & IEC 60601-IEC 60601-1 &Same

K250797 Page 6 of 10

Page 11

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
2-18 compliantIEC 60601-2-18 compliant
EMCIEC 60601-2 compliantIEC 60601-2 compliantSame
Adjust brightness of illumination of the LEDsAdjust by depressing a button on the handle to change settingsAdjust by depressing a button on the handle to change settingsSame
Images or video captureCapture still images (photo) or video during a procedure by depressing the camera button on the handleCapture still images (photo) or video during a procedure by depressing the camera button on the handleSame
Cleaning, disinfecting, and sterilizingThe handle is not sterile.The handle is cleaned and disinfected following directions in the instructions for use (IFU):• Wipe the surface with a Super Sani-Cloth or CaviWipe towelette• Surface to remain visibly wet for 3 minutes• After 3 minutes, allow the handle to air dry for 5 minutesWet a sterile pad with sterile water and wipe all exposed surfaces of the handle.The handle is not sterile.The handle is cleaned and disinfected following directions in the instructions for use (IFU):• Wipe the surface with a Super Sani-Cloth or CaviWipe towelette• Surface to remain visibly wet for 3 minutes• After 3 minutes, allow the handle to air dry for 5 minutesWet a sterile pad with sterile water and wipe allSame

K250797 Page 7 of 10

Page 12

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
exposed surfaces of the handle.
Frequency of useReuseableReusableSame
Duration of use< 24 hours< 24 hoursSame
Location of useHospitals and physician officesHospitals and physician officesSame
Mechanism of Action
Operating PrinciplesRather than run a cable from the cystoscope to a separate video monitor as is required for all other cystoscopes, the LCD monitor is integrated into the body of the handle of the UroViu cystoscope system so that the user can see images of the tissue and anatomical structures directly and in real time as the cystoscope is being advanced to and within the bladder.Rather than run a cable from the cystoscope to a separate video monitor as is required for all other cystoscopes, the LCD monitor is integrated into the body of the handle of the UroViu cystoscope system so that the user can see images of the tissue and anatomical structures directly and in real time as the cystoscope is being advanced to and within the bladder.Same
Performance Testing
Bench testing for Image QualityPassPassSame
Battery change and discharge testPassPassSame
3 Year service lifePassPassSame
Software (SW)
SW version1.04.1This SW version was developed separately but it used version 4.1

K250797 Page 8 of 10

Page 13

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Subject DeviceUV5000 HandleUroViu Corp.(This submission)Predicate DeviceUro-G HD Flexible CystoscopeUroViu Corp.K232837Equivalence
for the 4500 Handle as reference.
Level of ConcernModerateModerateSame
General functions of the software• Initialize and setup video processing software• Initialize LCD display control• Initialize user interface (menus, touch screen)• Initialize recording, storage, and playback of video and still images• Initialize and setup video processing software• Initialize LCD display control• Initialize user interface (menus, touch screen)• Initialize recording, storage, and playback of video and still imagesSame

Performance Data

All necessary performance testing as conducted:
• Field of view accuracy
• Direction of view
• Depth of Field
• Noise and Dynamic Range
• Image distortion
• Image resolution
• Image uniformity
• Color performance
• Electrical safety and electromagnetic compatibility testing

The device was found to meet the compliance requirements for electrical safety as specified in ISO 60601-1 including provisions for EMC safety in ISO 60601-1-2 and IEC 60601-2- 18 Medical electrical equipment - Part 2-18: Particular requirements for the basic safety and essential performance of endoscopic equipment, including thermal safety. Mechanical characteristics were also tested, with successful results.

K250797 Page 9 of 10

Page 14

UroViu Corporation Traditional 510(k) Notification
UV5000 Handle

Preclinical (Animal) Studies

Bench testing was sufficient to demonstrate performance of the device. No preclinical testing of the subject device was necessary.

Clinical Studies

Bench testing was sufficient to demonstrate performance of the device. No clinical testing of the subject device was necessary.

Conclusion

The information submitted in this premarket notification confirms that the minor differences between the UV5000 Handle and the predicate raise no new questions of safety and effectiveness. Therefore, the UV5000 Handle is substantially equivalent to the identified predicate device.

K250797 Page 10 of 10

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.